Reference priceJPY ¥745.50Original source price: INR 426.00. Converted estimates are available by currency selection.
| Brand | Concord Biotech Ltd |
|---|---|
| Manufacturer | Concord Biotech Ltd |
| Prescription required | Yes |
Evercon 0.25mg Tablet
Everolimus (0.25mg)
Description
Evercon 0.25 mg tablet is an antineoplastic drug belonging to the class of mTOR inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumours are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups is important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma.Benefits
Evercon 0.25mg Tablet is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.How to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Evercon Infection Fever Cough Fatigue Diarrhea Upper respiratory tract infectionこの情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。